NCT02031692View on ClinicalTrials.gov

Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV

PHASE4CompletedINTERVENTIONAL

Enrollment

1,050

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 26, 2017

Study Completion Date

June 15, 2017

Conditions

Benign Paroxysmal Positional Vertigo

Interventions

DRUG

400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

The patients allocated to the intervention group will have a test for serum vitamin D, and receive 800 IU of vitamin D and 1000 mg of calcium as calcium carbonate when the serum vitamin D is decreased. The patients in the control group will be followed up without intervention for one year.

Trial Locations (1)

463-707

Seoul National Universtiy Bundang Hospital, Seongnam-si

All Listed Sponsors

collaborator

Ministry of Food and Drug Safety, Korea

OTHER_GOV

lead

Seoul National University Bundang Hospital

OTHER

NCT02031692 - Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV | Biotech Hunter | Biotech Hunter